BLPH logo

Bellerophon Therapeutics, Inc.


BLPH: Bellerophon Therapeutics Inc is a clinical-stage therapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company's products are aimed at the treatment of different kinds of pulmonary hypertension.


Show BLPH Financials

Consumer Interest
SEC Filings

Recent trades of BLPH by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BLPH's directors and management

Government lobbying spending instances

  • $30,000 Jan 19, 2021 Issue: Health Issues Budget/Appropriations
  • $80,000 Oct 19, 2020 Issue: Budget/Appropriations Health Issues
  • $60,000 Jul 18, 2020 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BLPH in WallStreetBets Daily Discussion


Recent insights relating to BLPH

CNBC Recommendations

Recent picks made for BLPH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BLPH

Corporate Flights

Flights by private jets registered to BLPH